Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
SAO PAULO/FRANFURT - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZenecaFILE PHOTO: A small bottle labeled with a"Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic
A source familiar with the matter told Reuters that the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis vaccine. The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said the volunteer was Brazilian without revealing where the person lived.AstraZeneca vaccine trial would have stopped if deceased volunteer part of active arm - source
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Volunteer In AstraZeneca Covid-19 Vaccine Trial Reportedly Dies In BrazilThe company’s vaccine trial is currently on hold in the U.S.
Read more »
AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority saysBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.
Read more »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Read more »
AstraZeneca close to restarting Covid-19 vaccine trial in U.S.AstraZeneca is likely to restart its late-stage U.S. coronavirus vaccine trial 'very soon,' possibly later this week, according to one of the researchers leading the study
Read more »
Mainland China reports 19 new COVID-19 casesChina reported 19 new coronavirus cases in the mainland for Oct. 19, up from 13 cases a day earlier, the health commission said on Tuesday.
Read more »
Britain Moves Toward Ethically Controversial COVID-19 Vaccine TrialThe British government has announced plans for a coronavirus vaccine challenge trial. Volunteers will receive an experimental vaccine and be exposed to the virus to test its efficacy.
Read more »